NEW YORK (360Dx) – As Integrated Diagnostics prepares to launch its second-generation Xpresys Lung test, a study published this month in Chest finds the assay can rule out lung nodules as likely benign with a negative predictive value of 98 percent.
360Dx Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.